Kojin Therapeutics
Founded by Stuart Schreiber, Benjamin Cravatt, Stephanie Dougan, and Vasanthi Viswanathan, Kojin is accelerating a drug discovery platform that connects complex cell states to known biochemical processes such as ferroptosis, or iron-dependent cell death, and enables the development of selective therapies for a broad range of hard-to-treat diseases. The company’s investors include Polaris Partners, Newpath Partners, Cathay Health, Leaps by Bayer, AbbVie Inc., Eventide Asset Management, Alexandria, and the Dana-Farber Cancer Institute venture firm, Binney Street Capital.
Tech Stack (8 technologies)
Frequently Asked Questions
What technologies does Kojin Therapeutics use?+
Kojin Therapeutics uses 8 technologies including Google Analytics, Google Tag Manager, Cloudflare.
What industry is Kojin Therapeutics in?+
Kojin Therapeutics operates in the Biopharma industry.
Where is Kojin Therapeutics based?+
Kojin Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026